7 results
Industry

TSGA IPA: The Australian Aquatic Animal Health and Vaccine Centre: First Phase to Establish Atlantic Salmon Biosecure Fish Facility Capabilities and Develop Strategy for an Australian Centre of Excellence

Project number: 2013-051
Project Status:
Completed
Budget expenditure: $1,694,600.00
Principal Investigator: Jeremy Carson
Organisation: Department of Natural Resources and Environment Tasmania (NRE TAS)
Project start/end date: 23 Feb 2014 - 1 Aug 2015
Contact:
FRDC

Need

Commercial in confidence. To know more about this project please contact FRDC.

Objectives

Commercial in confidence

TSGA IPA: Establishing viral diagnostics for salmonid aquaculture in Tasmania: characterisation and identification of Salmon Orthomyxo-like virus (SOMV) and associated pathology in Atlantic Salmon

Project number: 2013-033
Project Status:
Completed
Budget expenditure: $497,382.00
Principal Investigator: Jeremy Carson
Organisation: Department of Natural Resources and Environment Tasmania (NRE TAS)
Project start/end date: 18 Nov 2013 - 17 Nov 2016
Contact:
FRDC

Need

Commercial in confidence. To know more about this project please contact FRDC.

Objectives

Commercial in confidence

Atlantic Salmon Aquaculture Subprogram: assessment of Orthomyxo-like virus pathogenicity in Atlantic salmon

Project number: 2012-053
Project Status:
Completed
Budget expenditure: $93,233.00
Principal Investigator: Richard Morrison
Organisation: Department of Natural Resources and Environment Tasmania (NRE TAS)
Project start/end date: 28 Feb 2013 - 31 Aug 2013
Contact:
FRDC

Need

Key Stakeholder Relevance
Since the inception of marine salmonid aquaculture in Tasmania during the 1980’s, a number of pathogens have emerged. The industry and DPIPWE have collaborated in developing/commercialising vaccines for several of these pathogens. This successful, ongoing strategy is used to mitigate disease in a practical, cost-effective and sustainable manner. These vaccines are effective however for known pathogens; the emergence of new pathogens presents the industry with an entirely new set of challenges. Viral pathogens, such as the Orthomyxo-like virus, are of particular concern to industry as there are no therapeutic agents available to treat virally-infected fish. This project was instigated on behalf of the Tasmanian salmon growers and the project aims to inform the salmonid aquaculture industry and government as to the potential for the virus to cause disease in Atlantic salmon.

Emerging Diseases: Data Provides Context
Little is known about the Orthomyxo-like virus associated with farmed Atlantic salmon. Investigation/analysis is hampered by a lack of information about the pathogenic capability of the Orthomyxo-like virus and limited histopathology description Orthomyxo-like virus infected fish. The proposed pathogenicity trial will determine if the Orthomyxo-like virus can act as a primary pathogen of Atlantic salmon in the absence of confounding external stressors. If the virus is shown to be pathogenic it will provide context for industry & government stakeholders to develop management, control and surveillance strategies.

The Proposed Project is Aligned with R&D Plans
This project is directly aligned with the following strategic plans;
•DPIPWE Corporate Plan 2011-14
•FRDC’s Strategic Priority Areas
oProgram 1: Environment
oTheme 1: Biosecurity, aquatic animal health
oProgram 2: Industry
oTheme 7: Production, growth, profitability
•FRDC Aquatic Animal Health Subprogram
oKey research areas
oNature of disease and host-pathogen interaction
oKnowledge about new/emerging infectious diseases
oAquatic animal health management

Objectives

1. Establish if the Orthomyxo-like virus can act as a primary pathogen and cause disease in Atlantic salmon.
2. Determine the stability of the Orthomyxo-like virus under varying environmental conditions.

Final report

Authors: R.N. Morrison J. Carson G. Knowles

Aquareovirus (TSRV) vaccine development for the Tasmanian salmonid aquaculture industry

Project number: 2011-224
Project Status:
Completed
Budget expenditure: $1,530,308.40
Principal Investigator: Richard Morrison
Organisation: Department of Natural Resources and Environment Tasmania (NRE TAS)
Project start/end date: 11 Jun 2012 - 19 Dec 2019
Contact:
FRDC

Need

Commercial in confidence. To know more about this project please contact FRDC.

Objectives

Commercial in confidence

Tasmanian Aquabirnavirus vaccine development: Towards achieving pan-specific protection of cultured salmonids in Australia using multivalent vaccines

Project number: 2010-032
Project Status:
Completed
Budget expenditure: $1,170,685.09
Principal Investigator: Richard Morrison
Organisation: Department of Natural Resources and Environment Tasmania (NRE TAS)
Project start/end date: 31 May 2010 - 20 Dec 2019
Contact:
FRDC

Need

Commercial in confidence. To know more about this project please contact FRDC.

Objectives

Commercial in confidence